Designing circulating tumor DNA-based interventional clinical trials in oncology
Editorial summary Circulating tumor (ct) DNA is a powerful tool that can be used to track cancer beyond a single snapshot in space and time. It has potential applications in detecting minimal residual disease and predicting relapse, in selecting patients for tailored treatments, and in revealing mec...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-04-01
|
| Series: | Genome Medicine |
| Online Access: | http://link.springer.com/article/10.1186/s13073-019-0634-x |